Cytel (United States)

Cambridge (United States us)
Economics and Econometrics
Adaptive Designs Clinical endpoint Circulating tumor cell Health Technology Assessment Cost-effectiveness Analysis Interim analysis Interim Fiber Amplifiers Treatment Adaptive design
Watch Introduction

Bibliometric indicators

Evolution over the last years of activity

Showing the period - Sept. 2024

1,217
Activity
3%

Total documents

2.31
Impact
3%

Normalized Impact

259
Excellence
3%

Highly Cited Papers (Top 10%)

64.5
Leadership
3%

Leadership (%)

39.5
Mobility & Collaboration
3%

International Collaboration (%)

47
Excellence
3%

Outstanding papers (Top 1%)

6.6
Leadership
3%

Women Leading (%)

2.2
Leadership
3%

Women Leading International (%)

43.6
Open Access
3%

Open Access (%)

Main Research Fields (top 9 by publications)

Indicators:

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Human Resources

Historical perspective

From to Sept. 2024

Current resources

Quick filters

Career Stage
Occasional Junior Researcher Senior Leading
Performance
Standard Good Excellent Outstanding
Gender
Male Female
Reset
0

Personnel

0.0

Papers / Personnel

0

Leading women (%)

0
0

Gender (%)

0

Papers / Permanent researchers

0

Papers / Leading researchers

Career stage

Performance

Years of Activity

ONE Index (distribution)

ONE Index by Main Research Fields

ONE Index vs. Years of Activity

Main authors

ID Name Gender Discipline Career Stage ONE Index Years Activity NDocs RCI HCP Leader Collab.
1 Mehta, Cyrus male Statistics and Probability Leading researcher 823 51 188 3.62 42 51.6% 32.5%
2 Harari, Ofir male Infectious Diseases, Statistics and Probability Researcher 774 13 62 4.41 15 17.7% 54.8%
3 Southwood, Scott male Immunology Leading researcher 749 34 125 3.65 61 1.6% 24.8%
4 Heeg, Bart male Economics and Econometrics Senior researcher 729 21 153 0.48 6 44.4% 58.8%
5 J. Kyle Wathen Statistics and Probability Junior researcher 720 2 11 0.00 0 54.6% 100.0%
6 James A. Bolognese Pharmacology Leading researcher 712 43 98 3.13 22 18.4% 24.5%
7 Zannat, N.E. Economics and Econometrics Junior researcher 668 3 8 0.00 0 50.0% 25.0%
8 Jean‐Marc P. Delavaux Electrical and Electronic Engineering Leading researcher 662 44 184 0.55 10 52.2% 15.2%
9 Alexandre male Electrical and Electronic Engineering Junior researcher 656 5 20 0.33 0 25.0% 30.0%
10 Robert Wayne Chesnut Immunology Leading researcher 629 66 128 2.39 42 29.7% 5.5%
11 Mukherjee, Rajat male Statistics and Probability Researcher 625 6 14 1.91 3 21.4% 64.3%
12 Nitin R. Patel Statistics and Probability Leading researcher 616 53 95 1.92 28 61.1% 22.1%
13 Forsythe, Anna female Hematology, Economics and Econometrics Leading researcher 609 46 152 0.50 7 50.7% 26.3%
14 Antonijevic, Zoran male Economics and Econometrics Senior researcher 609 15 30 1.23 6 46.7% 33.3%
15 Harricharan, Sharada female Economics and Econometrics Researcher 589 8 30 0.26 1 50.0% 26.7%
16 Bar‐Chaim, Nadav male Electrical and Electronic Engineering Leading researcher 568 52 93 0.79 10 52.7% 4.3%
17 Haggstrom, Jonas male Statistics and Probability, Nutrition and Dietetics Senior researcher 555 20 30 5.96 13 23.3% 46.7%
18 Gurjar, Khushboo female Economics and Econometrics Junior researcher 549 2 4 0.83 1 0.0% 75.0%
19 Laliman‐Khara, Victor male Rheumatology Junior researcher 548 2 3 3.91 2 33.3% 66.7%
20 Daisy Dandan Wang Oncology Researcher 544 11 21 2.03 7 0.0% 95.2%
21 Winnie female Rheumatology Researcher 543 9 17 1.31 3 0.0% 29.4%
22 Lawson, Kaitlyn female Physiology Junior researcher 529 3 5 8.16 1 0.0% 80.0%
23 Lin, Peter P. male Oncology Leading researcher 528 33 65 1.69 16 36.9% 60.0%
24 Mariano Jose Elices Immunology and Allergy Leading researcher 528 39 65 2.43 12 43.1% 7.7%
25 Xiao, Yongling Cardiology and Cardiovascular Medicine Senior researcher 509 27 87 0.91 13 16.1% 31.0%
823
One Index
 Mehta, Cyrus PhD   0000-0003-0724-3104 188 docs (1974 - 2023)  
Contingency table , Adaptive Designs , Type 2 Diabetes , Alogliptin , Interim analysis
774
One Index
 Harari, Ofir PhD   0000-0002-2901-0558 62 docs (2012 - 2024)  
Depression (economics) , Multiple Testing , 2019-20 coronavirus outbreak , Interim analysis , Interquartile range
749
One Index
 Southwood, Scott PhD 125 docs (1991 - 2015)  
CTL* , Peptide-MHC Binding , Antigen Presentation , T Cell Immunity , HLA Class I and II
729
One Index
 Heeg, Bart PhD   0000-0002-9226-3232 153 docs (2004 - 2024)  
Reimbursement , Daratumumab , Cost-effectiveness Analysis , Progression-free survival , Multiple Testing
720
One Index
 J. Kyle Wathen 11 docs (2023 - 2023)  
Adaptive design , Adaptive Designs , Research design , Clinical study design , Phase I Trials
712
One Index
 James A. Bolognese PhD 98 docs (1982 - 2024)  
Tolerability , Clinical endpoint , Etoricoxib , Pain Modulation , Diclofenac
668
One Index
 Zannat, N.E. 8 docs (2022 - 2023)  
Cost-effectiveness Analysis , Antirheumatic drugs , Axial spondyloarthritis , Nice , Work productivity
662
One Index
 Jean‐Marc P. Delavaux PhD 184 docs (1981 - 2024)  
Fiber Amplifiers , Erbium , Fiber Lasers , Thulium , Optical Performance Monitoring
656
One Index
 Alexandre   0000-0002-9995-727X 20 docs (2020 - 2024)  
Fiber Amplifiers , Watt , Fiber Lasers , High-Power Lasers , Microstructured Optical Fibers
629
One Index
 Robert Wayne Chesnut PhD 128 docs (1959 - 2014)  
CTL* , Antigen Presentation , T Cell Immunity , Crystal Structures , Continuous Crystallization
625
One Index
 Mukherjee, Rajat PhD   0000-0001-7905-2767 14 docs (2019 - 2024)  
Interim , Interim analysis , Adaptive Designs , Timeline , Clinical endpoint
616
One Index
 Nitin R. Patel PhD 95 docs (1972 - 2024)  
Contingency table , Cajanus , Categorical variable , Exact statistics , Sample (material)
609
One Index
 Forsythe, Anna PhD   0000-0001-6017-1926 152 docs (1979 - 2023)  
Eltrombopag , Health Technology Assessment , Romiplostim , Cost-effectiveness Analysis , Progression-free survival
609
One Index
 Antonijevic, Zoran PhD 30 docs (2010 - 2023)  
Drug development , Adaptive Designs , Drug Development Costs , Clinical study design , Cost-effectiveness Analysis
589
One Index
 Harricharan, Sharada PhD 30 docs (2017 - 2024)  
Health Technology Assessment , Nice , Discontinuation , Health technology , Reimbursement
568
One Index
 Bar‐Chaim, Nadav PhD 93 docs (1973 - 2002)  
Semiconductor Lasers , Passively Mode-Locked Lasers , Vertical-Cavity Surface-Emitting Lasers (VCSELs) , Board-Level Optical Interconnects , Raman Lasers
555
One Index
 Haggstrom, Jonas PhD   0000-0001-8304-9528 30 docs (2005 - 2024)  
Child Development , Maternal and Child Undernutrition , Pandemic , Data sharing , Adaptive Designs
549
One Index
 Gurjar, Khushboo 4 docs (2023 - 2024)  
Treatment Adherence , Medication Adherence , Medication Persistence , Persistence (discontinuity) , Nice
548
One Index
 Laliman‐Khara, Victor 3 docs (2023 - 2024)  
Disease-Modifying Antirheumatic Drugs , Patient Similarity , Temporal Data Analysis
544
One Index
 Daisy Dandan Wang PhD 21 docs (2014 - 2024)  
Circulating tumor cell , Cancer Genomics , Tumor Evolution , Intratumor Heterogeneity , Cell Plasticity
543
One Index
 Winnie PhD   0000-0002-5222-9187 17 docs (2016 - 2024)  
Abatacept , Disease-Modifying Antirheumatic Drugs , TNF inhibitor , Rheumatoid factor , Combination therapy
529
One Index
 Lawson, Kaitlyn 5 docs (2022 - 2023)  
Asthma , Treatment , Clinical endpoint , Medication Adherence , Salmeterol
528
One Index
 Lin, Peter P. PhD   0000-0002-6869-9490 65 docs (1992 - 2024)  
Circulating tumor cell , Intratumor Heterogeneity , Cell Plasticity , Cancer Genomics , Tumor Evolution
528
One Index
 Mariano Jose Elices PhD 65 docs (1986 - 2024)  
Cell Adhesion , Galactosyltransferase , VCAM-1 , Dermatopathology , Alpha (finance)
509
One Index
 Xiao, Yongling PhD 87 docs (1998 - 2024)  
Ustekinumab , Abiraterone acetate , Enzalutamide , Marginal structural model , Crohn disease